Life Science News

Latest updates from the biotech and pharma world

BioWorld 2026-02-09

Appointments and advancements for Feb. 9, 2026

BioWorld 2026-02-09

Financings for Feb. 9, 2026

BioWorld 2026-02-09

In the clinic for Feb. 9, 2026

BioWorld 2026-02-09

Other news to note for Feb. 9, 2026

BioWorld 2026-02-09

Regulatory actions for Feb. 9, 2026

BioWorld 2026-02-09

Innovent-Lilly $8.5B deal signals new China inflection point

BioWorld 2026-02-09

Biggest gainers and losers for Feb. 2-6, 2026

BioWorld 2026-02-09

Venenum Biodesign discloses new MOGAT2 inhibitors

BioWorld 2026-02-09

Korean researchers report new HER1/HER2 mutant inhibitors

BioWorld 2026-02-09

Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists

BioWorld 2026-02-06

Idorsia gets FDA-backed route to approval for oral Fabry drug

BioWorld 2026-02-06

More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M

BioWorld 2026-02-06

Bayer’s asundexian cuts stroke risk 26% in phase III win

BioWorld 2026-02-06

Money raised by biopharma

BioWorld 2026-02-06

Biopharma money raised: Jan. 1-Feb. 5, 2026

BioWorld 2026-02-06

BioWorld and Nasdaq stock indices

BioWorld 2026-02-06

Biopharma money raised by month in 2026 (US$M)

BioWorld 2026-02-06

Trump’s drug-discount website goes live

BioWorld 2026-02-06

ALTx formed to drug pathway by which cancer cells become immortal

BioWorld 2026-02-06

O-GlcNAcase inhibitors reported in Tyk Medicines patent

-317 / 28